Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 8—August 2025
Research
Rapid Emergence and Evolution of SARS-CoV-2 Intrahost Variants among COVID-19 Patients with Prolonged Infections, Singapore
Table 2
Clinical features of patients in a study of rapid emergence and evolution of SARS-CoV-2 intrahost variants among COVID-19 patients with prolonged infections, Singapore*
Characteristics | All patients, n = 20 |
---|---|
Median age, y (range) |
38 (21–70) |
Sex | |
F | 6 (30) |
M |
14 (70) |
Healthcare worker |
2 (10) |
Median height, cm (range) | 168 (151–185) |
Median weight, kg (range) | 69.2 (42.5–95.1) |
Median BMI (range) |
25.8 (14.7–31.8) |
Hypertension |
4 (20) |
Intensive care unit admission | 2 (10) |
Median length of hospitalization, d (range) |
7 (4–40) |
Median CRP, mg/L (IQR) |
41.53 (14.1–109.7) |
Median leukocyte count, cells × 109/L (range) | 4.99 (2.5–21.7) |
Median lymphocyte count, cells × 109/L (IQR) |
1.27 (0.97–1.68) |
Remdesivir treatment | 5 (25) |
Long-term medication |
4 (20) |
International travel | 8 (40) |
*Values are no. (%) except as indicated. BMI, body mass index; CRP, C-reactive protein; IQR, interquartile range.
Page created: May 31, 2025
Page updated: July 01, 2025
Page reviewed: July 01, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.